Clinical Trial Update: Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating montelukast (Singulair) for nonallergic rhinitis with eosinophilia syndrome (NARES); current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonallergic Rhinitis with Eosinophilia Syndrome

Drugs mentioned

• SINGULAIR (montelukast)

Snippet

Sponsor: Bernstein, Jonathan A., M.D. | Conditions: Rhinitis | Phase 4 | Status: UNKNOWN